Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply

Affiliations

¹ Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: xhzlwg@163.com.

Comment

Kunyu Yang et al. Lancet Oncol. 2020 Sep.

. 2020 Sep;21(9):e408.

doi: 10.1016/S1470-2045(20)30467-8.

¹ Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: xhzlwg@163.com.

No abstract available

Comment on

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, Pan D, Shu C, Li J, Wei J, Huang Y, Peng L, Wu M, Zhang R, Wu B, Li Y, Cai L, Li G, Zhang T, Wu G. Yang K, et al. Lancet Oncol. 2020 Jul;21(7):904-913. doi: 10.1016/S1470-2045(20)30310-7. Epub 2020 May 29. Lancet Oncol. 2020. PMID: 32479787 Free PMC article.
Risk factors for in-hospital mortality in patients with cancer and COVID-19.
Guo K, Sun L, Yuan L, Wasan HS, Ruan S. Guo K, et al. Lancet Oncol. 2020 Sep;21(9):e406. doi: 10.1016/S1470-2045(20)30426-5. Lancet Oncol. 2020. PMID: 32888456 Free PMC article. No abstract available.
Risk factors for in-hospital mortality in patients with cancer and COVID-19.
Zhang G, An Y, Zhang L, Xie L, Guo X. Zhang G, et al. Lancet Oncol. 2020 Sep;21(9):e407. doi: 10.1016/S1470-2045(20)30390-9. Lancet Oncol. 2020. PMID: 32888457 Free PMC article. No abstract available.

1. Yang K, Sheng Y, Huang C. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21:904–913. - PMC - PubMed
1. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
1. Ay C, Vormittag R, Dunkler D. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2009;27:4124–4129. - PubMed
1. Dirix LY, Salgado R, Weytjens R. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86:389–395. - PMC - PubMed